Mirati Therapeutics, Inc.
MRTXNASDAQHealthcare
$58.70
$-0.10(-0.17%)
Market Cap$4.1B
P/E Ratio—
52W High$64.41
52W Low$27.3
Mirati Therapeutics, Inc.（MRTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MRTX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.44M | $72.09M | $13.40M | $3.33M | $12.93M |
| Cost of Revenue | $0.60M | $1.78M | $299.35M | $182.87M | $93.87M |
| Gross Profit | $11.84M | ($436.50M) | ($285.95M) | ($179.53M) | ($80.95M) |
| Gross Margin %(computed) | 95.18% | -605.48% | — | — | -626.23% |
| Operating Expenses | |||||
| R&D Expenses | $531.63M | $508.59M | $299.35M | $182.87M | $93.87M |
| G&A Expenses | $0.00M | $136.68M | $83.41M | $42.57M | $21.68M |
| Total Operating Expenses | $771.42M | $645.27M | $382.76M | $33.73M | $115.55M |
| Operating Income | ($759.59M) | ($573.18M) | ($369.36M) | ($222.10M) | ($102.63M) |
| Operating Margin %(computed) | — | -795.07% | — | — | -793.96% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($740.36M) | ($578.49M) | ($357.94M) | ($213.26M) | ($98.42M) |
| Income Tax Expense | $0.51M | $3.30M | ($0.51M) | ($0.66M) | $0.00M |
| Net Income | ($740.87M) | ($581.78M) | ($357.94M) | ($213.26M) | ($98.42M) |
| Net Margin %(computed) | — | -807.00% | — | — | -761.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-13.18 | $-11.21 | $-7.96 | $-5.69 | $-3.19 |
| Wtd Avg Shares | 56.23M | 51.88M | 44.99M | 37.47M | 30.90M |
| EBITDA | ($756.66M) | ($571.40M) | ($368.72M) | ($221.85M) | ($102.63M) |
| EBITDA Margin %(computed) | — | -792.60% | — | — | -793.96% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Mirati Therapeutics, Inc.
关于Mirati Therapeutics, Inc.（MRTX）损益表
Mirati Therapeutics, Inc.（MRTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，MRTX实现营收$0.01B，毛利润$0.01B（毛利率95.18%），净利润($0.74B)（净利率-5957.44%）。
常见问题
MRTX · 4 问Mirati Therapeutics, Inc.（MRTX）2022财年营收为$0.01B，同比down82.7%。
MRTX revenueMRTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09